# BlueLinx Holdings Inc.: financial statements, quarterly

BXC · NYSE · CIK 1301787 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/bxc.md) · [Financials](/companies/bxc/financials.md) · [Filings](/companies/bxc/filings.md) · [Insiders](/companies/bxc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bxc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [810](/filings/0001301787-24-000032.md) | [713 d](/filings/0001628280-26-011136.md) | [726](/filings/0001301787-25-000021.md) | [768](/filings/0001301787-25-000028.md) | [747](/filings/0001628280-25-048857.md) | [711 d](/filings/0001628280-26-011136.md) | [709](/filings/0001628280-26-030607.md) | [780](/filings/0001628280-26-052605.md) | [749](/filings/0001628280-25-048857.md) | [716 d](/filings/0001628280-26-011136.md) | [731](/filings/0001628280-26-030607.md) | [814](/filings/0001628280-26-052605.md) |
| Cost of revenue | $m | [671](/filings/0001301787-24-000032.md) | [594 d](/filings/0001628280-26-011136.md) | [599](/filings/0001301787-25-000021.md) | [646](/filings/0001301787-25-000028.md) | [622](/filings/0001628280-25-048857.md) | [597 d](/filings/0001628280-26-011136.md) | [598](/filings/0001628280-26-030607.md) | [660](/filings/0001628280-26-052605.md) | [641](/filings/0001628280-25-048857.md) | [603 d](/filings/0001628280-26-011136.md) | [615](/filings/0001628280-26-030607.md) | [674](/filings/0001628280-26-052605.md) |
| Gross profit | $m | [139](/filings/0001301787-24-000032.md) | [118 d](/filings/0001628280-26-011136.md) | [128](/filings/0001301787-25-000021.md) | [122](/filings/0001301787-25-000028.md) | [126](/filings/0001628280-25-048857.md) | [113 d](/filings/0001628280-26-011136.md) | [111](/filings/0001628280-26-030607.md) | [120](/filings/0001628280-26-052605.md) | [108](/filings/0001628280-25-048857.md) | [113 d](/filings/0001628280-26-011136.md) | [116](/filings/0001628280-26-030607.md) | [140](/filings/0001628280-26-052605.md) |
| Selling, general and administrative | $m | [91.4](/filings/0001301787-24-000032.md) | [84.5 d](/filings/0001628280-26-011136.md) | [91.3](/filings/0001301787-25-000021.md) | [89.5](/filings/0001301787-25-000028.md) | [92.2](/filings/0001628280-25-048857.md) | [92.6 d](/filings/0001628280-26-011136.md) | [94.1](/filings/0001628280-26-030607.md) | [95.3](/filings/0001628280-26-052605.md) | [89.3](/filings/0001628280-25-048857.md) | [102 d](/filings/0001628280-26-011136.md) | [96.2](/filings/0001628280-26-030607.md) | [107](/filings/0001628280-26-052605.md) |
| Operating income | $m | [39.7](/filings/0001301787-24-000032.md) | [27.2 d](/filings/0001628280-26-011136.md) | [27.7](/filings/0001301787-25-000021.md) | [23.8](/filings/0001301787-25-000028.md) | [24.0](/filings/0001628280-25-048857.md) | [12.0 d](/filings/0001628280-26-011136.md) | [10.7](/filings/0001628280-26-030607.md) | [15.0](/filings/0001628280-26-052605.md) | [10.0](/filings/0001628280-25-048857.md) | [(3.2) d](/filings/0001628280-26-011136.md) | [7.3](/filings/0001628280-26-030607.md) | [20.6](/filings/0001628280-26-052605.md) |
| Interest expense | $m | [5.6](/filings/0001301787-23-000078.md) | [4.2 d](/filings/0001301787-24-000009.md) | [4.6](/filings/0001301787-24-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.1](/filings/0001301787-24-000032.md) | [10.1 d](/filings/0001628280-26-011136.md) | [5.6](/filings/0001301787-25-000021.md) | [4.7](/filings/0001301787-25-000028.md) | [5.6](/filings/0001628280-25-048857.md) | [1.7 d](/filings/0001628280-26-011136.md) | [1.3](/filings/0001628280-26-030607.md) | [2.3](/filings/0001628280-26-052605.md) | [(0.3)](/filings/0001628280-25-048857.md) | [(3.4) d](/filings/0001628280-26-011136.md) | [(0.4)](/filings/0001628280-26-030607.md) | [4.8](/filings/0001628280-26-052605.md) |
| Net income | $m | [24.4](/filings/0001301787-24-000032.md) | [(18.1) d](/filings/0001628280-26-011136.md) | [17.5](/filings/0001628280-25-048857.md) | [14.3](/filings/0001628280-25-048857.md) | [16.0](/filings/0001628280-25-048857.md) | [5.3 d](/filings/0001628280-26-011136.md) | [2.8](/filings/0001628280-26-052605.md) | [4.3](/filings/0001628280-26-052605.md) | [1.7](/filings/0001628280-25-048857.md) | [(8.6) d](/filings/0001628280-26-011136.md) | [(1.5)](/filings/0001628280-26-052605.md) | [6.4](/filings/0001628280-26-052605.md) |
| Diluted EPS | $ per share | [2.71](/filings/0001301787-24-000032.md) | not reported | [2.00](/filings/0001301787-25-000021.md) | [1.65](/filings/0001301787-25-000028.md) | [1.87](/filings/0001628280-25-048857.md) | not reported | [0.33](/filings/0001628280-26-030607.md) | [0.54](/filings/0001628280-26-052605.md) | [0.20](/filings/0001628280-25-048857.md) | not reported | [(0.18)](/filings/0001628280-26-030607.md) | [0.81](/filings/0001628280-26-052605.md) |
| Basic EPS | $ per share | [2.72](/filings/0001301787-24-000032.md) | not reported | [2.02](/filings/0001301787-25-000021.md) | [1.65](/filings/0001301787-25-000028.md) | [1.88](/filings/0001628280-25-048857.md) | not reported | [0.33](/filings/0001628280-26-030607.md) | [0.54](/filings/0001628280-26-052605.md) | [0.20](/filings/0001628280-25-048857.md) | not reported | [(0.18)](/filings/0001628280-26-030607.md) | [0.82](/filings/0001628280-26-052605.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [470](/filings/0001301787-23-000078.md) | [522](/filings/0001301787-25-000012.md) | [481](/filings/0001301787-24-000017.md) | [491](/filings/0001301787-24-000024.md) | [526](/filings/0001301787-24-000032.md) | [506](/filings/0001628280-26-011136.md) | [449](/filings/0001301787-25-000021.md) | [387](/filings/0001301787-25-000028.md) | [429](/filings/0001628280-25-048857.md) | [386](/filings/0001628280-26-052605.md) | [319](/filings/0001628280-26-030607.md) | [318](/filings/0001628280-26-052605.md) |
| Current assets | $m | [1,171](/filings/0001301787-23-000078.md) | [1,120](/filings/0001301787-25-000012.md) | [1,173](/filings/0001301787-24-000017.md) | [1,159](/filings/0001301787-24-000024.md) | [1,181](/filings/0001301787-24-000032.md) | [1,134](/filings/0001628280-26-011136.md) | [1,166](/filings/0001301787-25-000021.md) | [1,105](/filings/0001301787-25-000028.md) | [1,099](/filings/0001628280-25-048857.md) | [984](/filings/0001628280-26-052605.md) | [1,045](/filings/0001628280-26-030607.md) | [1,061](/filings/0001628280-26-052605.md) |
| Total assets | $m | [1,585](/filings/0001301787-23-000078.md) | [1,538](/filings/0001301787-25-000012.md) | [1,592](/filings/0001301787-24-000017.md) | [1,586](/filings/0001301787-24-000024.md) | [1,611](/filings/0001301787-24-000032.md) | [1,578](/filings/0001628280-26-011136.md) | [1,633](/filings/0001301787-25-000021.md) | [1,584](/filings/0001301787-25-000028.md) | [1,582](/filings/0001628280-25-048857.md) | [1,549](/filings/0001628280-26-052605.md) | [1,598](/filings/0001628280-26-030607.md) | [1,604](/filings/0001628280-26-052605.md) |
| Current liabilities | $m | [268](/filings/0001301787-23-000078.md) | [219](/filings/0001301787-25-000012.md) | [249](/filings/0001301787-24-000017.md) | [237](/filings/0001301787-24-000024.md) | [258](/filings/0001301787-24-000032.md) | [234](/filings/0001628280-26-011136.md) | [281](/filings/0001301787-25-000021.md) | [243](/filings/0001301787-25-000028.md) | [239](/filings/0001628280-25-048857.md) | [211](/filings/0001628280-26-052605.md) | [268](/filings/0001628280-26-030607.md) | [265](/filings/0001628280-26-052605.md) |
| Total liabilities | $m | [954](/filings/0001301787-23-000078.md) | [903](/filings/0001301787-25-000012.md) | [938](/filings/0001301787-24-000017.md) | [934](/filings/0001301787-24-000024.md) | [955](/filings/0001301787-24-000032.md) | [931](/filings/0001628280-26-011136.md) | [997](/filings/0001301787-25-000021.md) | [963](/filings/0001301787-25-000028.md) | [959](/filings/0001628280-25-048857.md) | [932](/filings/0001628280-26-052605.md) | [983](/filings/0001628280-26-030607.md) | [982](/filings/0001628280-26-052605.md) |
| Long-term debt | $m | [293](/filings/0001301787-23-000078.md) | [294](/filings/0001301787-25-000012.md) | [294](/filings/0001301787-24-000017.md) | [294](/filings/0001301787-24-000024.md) | [295](/filings/0001301787-24-000032.md) | [295](/filings/0001628280-26-011136.md) | [295](/filings/0001301787-25-000021.md) | [296](/filings/0001301787-25-000028.md) | [296](/filings/0001628280-25-048857.md) | [297](/filings/0001628280-26-052605.md) | [297](/filings/0001628280-26-030607.md) | [297](/filings/0001628280-26-052605.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [632](/filings/0001301787-24-000032.md) | [634](/filings/0001628280-26-011136.md) | [653](/filings/0001628280-25-048857.md) | [652](/filings/0001628280-25-048857.md) | [656](/filings/0001628280-25-048857.md) | [646](/filings/0001628280-26-052605.md) | [636](/filings/0001628280-26-052605.md) | [621](/filings/0001628280-26-052605.md) | [623](/filings/0001628280-25-048857.md) | [617](/filings/0001628280-26-052605.md) | [616](/filings/0001628280-26-052605.md) | [621](/filings/0001628280-26-052605.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [77.6 d](/filings/0001301787-24-000032.md) | [75.6 d](/filings/0001628280-26-011136.md) | [(31.1)](/filings/0001301787-25-000021.md) | [35.8 d](/filings/0001301787-25-000028.md) | [61.8 d](/filings/0001628280-25-048857.md) | [18.7 d](/filings/0001628280-26-011136.md) | [(33.9)](/filings/0001628280-26-030607.md) | [(26.8) d](/filings/0001628280-26-052605.md) | [58.6 d](/filings/0001628280-25-048857.md) | [61.8 d](/filings/0001628280-26-011136.md) | [(57.2)](/filings/0001628280-26-030607.md) | [11.2 d](/filings/0001628280-26-052605.md) |
| Capital expenditure | $m | [4.9 d](/filings/0001301787-24-000032.md) | [8.6 d](/filings/0001628280-26-011136.md) | [5.4](/filings/0001301787-25-000021.md) | [6.5 d](/filings/0001301787-25-000028.md) | [7.9 d](/filings/0001628280-25-048857.md) | [20.3 d](/filings/0001628280-26-011136.md) | [5.9](/filings/0001628280-26-030607.md) | [9.6 d](/filings/0001628280-26-052605.md) | [5.9 d](/filings/0001628280-25-048857.md) | [5.4 d](/filings/0001628280-26-011136.md) | [2.6](/filings/0001628280-26-030607.md) | [2.4 d](/filings/0001628280-26-052605.md) |
| Share repurchases | $m | [17.7 d](/filings/0001301787-24-000032.md) | [12.8 d](/filings/0001628280-26-011136.md) | [0.0](/filings/0001301787-25-000021.md) | [14.5 d](/filings/0001301787-25-000028.md) | [15.5 d](/filings/0001628280-25-048857.md) | [15.3 d](/filings/0001628280-26-011136.md) | [15.0](/filings/0001628280-26-030607.md) | [20.4 d](/filings/0001628280-26-052605.md) | [2.7 d](/filings/0001628280-25-048857.md) | [0.0 d](/filings/0001628280-26-011136.md) | [2.8](/filings/0001628280-26-030607.md) | [2.6 d](/filings/0001628280-26-052605.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [9,328](/filings/0001301787-23-000078.md) | [9,157](/filings/0001301787-24-000017.md) | [9,057](/filings/0001301787-24-000024.md) | [8,970](/filings/0001301787-24-000032.md) | [8,742](/filings/0001301787-25-000021.md) | [8,686](/filings/0001301787-25-000028.md) | [8,528](/filings/0001628280-25-048857.md) | [8,328](/filings/0001628280-26-030607.md) | [7,977](/filings/0001628280-26-052605.md) | [7,946](/filings/0001628280-25-048857.md) | [7,943](/filings/0001628280-26-030607.md) | [7,859](/filings/0001628280-26-052605.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,860,217 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052605.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.